Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4963115 | 6160385 | F | 4963115-5 | 20060211 | 20060327 | 20060405 | EXP | ES-GLAXOSMITHKLINE-B0419016A | GLAXOSMITHKLINE | 85 | YR | M | Y | 20060405 | CN | SPAIN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
4963115 | 1007131893 | PS | AMOXICILLIN + CLAVULANATE POTASSIUM | 1 | ORAL | 50564 | |||||
4963115 | 1007131894 | C | ADIRO | 2 | ORAL | 100MG PER DAY | |||||
4963115 | 1007131895 | C | OMEPRAZOLE | 1 | ORAL | 20MG PER DAY | |||||
4963115 | 1007131896 | C | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 1 | ORAL |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
4963115 | 1007131893 | UPPER RESPIRATORY TRACT INFECTION |
4963115 | 1007131894 | ESSENTIAL HYPERTENSION |
4963115 | 1007131895 | PROPHYLAXIS |
4963115 | 1007131896 | ESSENTIAL HYPERTENSION |
Outcome of event
Event ID | OUTC COD |
---|---|
4963115 | HO |
Reactions reported
Event ID | PT |
---|---|
4963115 | HEPATITIS CHOLESTATIC |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
4963115 | 1007131893 | 20060201 | 20060212 | ||
4963115 | 1007131894 | 20050101 | |||
4963115 | 1007131895 | 20050101 | 20060214 | ||
4963115 | 1007131896 | 20050101 | 20060214 |